Cn /En

News Center

——

Company news

Industry news

Application Prospects of InnoModels High Mesenchymal Tumor Model

Author:

InnoModels

Release time:

2024-09-20

In the broad field of tumor research and new drug development for tumor immunotherapy, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully launched a high mesenchymal tumor transplantation model by virtue of its profound accumulation and technological innovation in the field of model construction, which provides strong support for tumor research and drug development. In this article, we will introduce in detail how InnoModels Biotechnology has made a breakthrough in this field, and explain the importance of high mesenchymal tumor models and their application prospects.
Importance of high mesenchymal tumor models
Tumor tissue microenvironment (TME) is one of the core components of tumor biology research, which contains a variety of cancer-associated fibroblasts (CAF), infiltrating immune cells, and extracellular matrix, etc. CAF and collagen matrix products are the main components of the stroma of connective tissue proliferative cancers, which account for a large proportion of the tumor mass, and play a key role in tumor growth, angiogenesis, and invasion. Therefore, the construction of tumor models that can accurately simulate this complex microenvironment is crucial for an in-depth understanding of the biological mechanisms of tumors and the development of novel anti-tumor drugs.
Technological Innovation of InnoModels
Based on the concept of co-construction of human mesenchymal stem cells (MSCs) and tumor cells, InnoModels has successfully constructed a high mesenchymal cell tumor transplantation model. This innovative model significantly increases the proportion of mesenchymal stromal cells in tumor tissues, making it closer to the actual clinical situation and providing a more reliable experimental platform for tumor research and drug development.

In the experiment, InnoModels Biotechnology found that when Miapaca2 cells were co-inoculated with MSCs, the growth rate and mean time of the tumors were significantly increased compared to Miapaca-2 cells alone. Meanwhile, by histological examination, the tumors in the co-inoculated group had richer tissue structures and more fibroblast structures. In addition, the results of flow analysis showed that the proportion of CD105, a marker for MSCs, was slightly increased but overall lower in the mixed MSC-inoculated tumors, which might be due to the fact that the inoculated MSCs had already undergone differentiation. Another important finding was that mixed MSC inoculation significantly reduced the number of murine-derived immune cells infiltrated in the tumors, which may be related to the increased stability and speed of tumor growth.
Application prospects of high mesenchymal tumor models
The highly mesenchymal tumor model constructed by InnoModels Biotechnology is promising for a wide range of applications in several aspects. First, the model can more accurately simulate the clinical tumor microenvironment, providing a more realistic experimental platform for the study of tumor biological mechanisms. Second, the model allows researchers to more effectively evaluate the effects of antitumor drugs, especially in the development of targeted drugs against CAF cells and related signaling pathways. In addition, the model can also be used to assess the effect of tumor immunotherapy, providing an important basis for the optimization of tumor immunotherapy.
Advantages of InnoModels' platform
InnoModels Biotechnology has not only achieved remarkable results in the construction of high mesenchymal tumor models, but also constructed a variety of advanced model platforms, including the PDX model, the PBMC-PDC in vitro co-killing screening platform, and the PBMC-PDX dual humanized model. Together, these platforms constitute the Thermo Scientific high-throughput generic clinical research platform, which can meet the needs of the entire process of new drug development from in vitro screening to in vivo validation. Through this platform, researchers can conduct high-throughput, low-cost pharmacodynamic testing of drugs in the preclinical stage, thereby substantially improving the success and efficiency of new drug development.
Conclusion
With its innovative high mesenchymal tumor model technology, InnoModels Biotechnology has opened up a new path for tumor research and drug development. The launch of this model not only enriches the tumor model library, but also provides strong support for the research of tumor biological mechanisms and the development of anti-tumor drugs. In the future, with the continuous progress of the technology and the in-depth expansion of the application, InnoModels Biotechnology is expected to play an even more important role in the field of tumor research, and make greater contributions to the cause of human health.

In Vitro Killing Experimental Platform from InnoModels Biotechnology

Advantages of the 3D Organoid Platform of InnoModels Biotechnology

In Vitro Killing Experimental Platform from InnoModels Biotechnology

Advantages of the 3D Organoid Platform of InnoModels Biotechnology

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License